EyePoint Pharmaceuticals (EYPT) Net Income: 2010-2018
Historic Net Income for EyePoint Pharmaceuticals (EYPT) over the last 8 years, with Sep 2018 value amounting to -$14.4 million.
- EyePoint Pharmaceuticals' Net Income fell 139.24% to -$14.4 million in Q3 2018 from the same period last year, while for Sep 2018 it was -$34.6 million, marking a year-over-year decrease of 99.88%. This contributed to the annual value of -$53.2 million for FY2018, which is 187.64% down from last year.
- According to the latest figures from Q3 2018, EyePoint Pharmaceuticals' Net Income is -$14.4 million, which was down 46.89% from -$9.8 million recorded in Q2 2018.
- EyePoint Pharmaceuticals' 5-year Net Income high stood at $20.6 million for Q3 2014, and its period low was -$14.4 million during Q3 2018.
- Its 3-year average for Net Income is -$6.4 million, with a median of -$6.0 million in 2017.
- Its Net Income has fluctuated over the past 5 years, first surged by 657.80% in 2014, then slumped by 8,568.66% in 2017.
- Over the past 5 years, EyePoint Pharmaceuticals' Net Income (Quarterly) stood at -$4.1 million in 2014, then decreased by 27.26% to -$5.2 million in 2015, then surged by 98.71% to -$67,000 in 2016, then slumped by 8,568.66% to -$5.8 million in 2017, then tumbled by 139.24% to -$14.4 million in 2018.
- Its Net Income stands at -$14.4 million for Q3 2018, versus -$9.8 million for Q2 2018 and -$4.7 million for Q1 2018.